TNFRSF10A antibody (C-Term)
Quick Overview for TNFRSF10A antibody (C-Term) (ABIN2574937)
Target
See all TNFRSF10A AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- C-Term
-
Specificity
- Recognizes endogenous levels of DR4 protein.
-
Purification
- Immunoaffinity purified
-
Immunogen
-
KLH-conjugated synthetic peptide encompassing a sequence within the C-terminal region of human DR4.
Type of Immunogen: Synthetic peptide
-
-
-
-
Application Notes
- Approved: IP (1:10 - 1:100), WB (1:500 - 1:1000)
-
Comment
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- PBS, pH 7.3, 0.01 % sodium azide, 30 % glycerol.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Aliquot to avoid freeze/thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C. Aliquot to avoid freeze/thaw cycles.
-
-
- TNFRSF10A (Tumor Necrosis Factor Receptor Superfamily, Member 10a (TNFRSF10A))
-
Alternative Name
- TNFRSF10A / DR4
-
Background
-
Name/Gene ID: TNFRSF10A
Family: TNF Receptor
Synonyms: TNFRSF10A, APO2, CD261, DR4, TRAIL-R1, TRAILR-1, TRAILR1, TRAIL receptor 1, CD261 antigen, Cytotoxic TRAIL receptor, Death receptor 4 -
Gene ID
- 8797
-
Pathways
- Apoptosis, Positive Regulation of Endopeptidase Activity
Target
-